GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

CLEVELAND - A new study published by Cleveland Clinic researchers investigating the genetic underpinnings of weight loss response has identified a ...

Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

DR NELLY KAMWALEKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 diabetes and obesity. Two drugs, Semaglutide and Tirzepatide ...

Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Engineers at Georgia Tech developed a new mode of delivery for injectable medications — an 'exploding' capsule.

Ozempic is a popular drug that, although is meant for diabetic patients, it is more so known for its weight loss side-effect. A small study has found an important aspect of diet for them.

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...